ReGenX Biosciences LLC, Voyager Therapeutics Inc. deal

ReGenX granted Voyager a non-exclusive, worldwide license to NAV vector technology for development and commercialization of gene therapies to treat amyotrophic lateral sclerosis (ALS), Friedreich's at...